Table 1.
Demographic and clinical characteristics of patients associated with the P-strains (n = 124) from the study panel.
| Demographic/clinical variable | Number of patients | % |
|---|---|---|
| Age | ||
| < 20 | 11/124 | 8.9 |
| 20–29 | 10/124 | 8.1 |
| 30–39 | 13/124 | 10.5 |
| 40–49 | 11/124 | 8.9 |
| 50–59 | 17/124 | 13.7 |
| 60–69 | 22/124 | 17.7 |
| 70–79 | 22/124 | 17.7 |
| 80–89 | 14/124 | 11.3 |
| ≥ 90 | 4/124 | 3.2 |
| Gender | ||
| M | 81/124 | 65.3 |
| F | 43/124 | 34.7 |
| Comorbidities and immune status* | ||
| Comorbidities | 103/118 | 87.3 |
| Immunocompromised | 60/116 | 51.7 |
| Charlson comorbidity index score* | ||
| 0 | 18/117 | 15.4 |
| 1 | 11/117 | 9.4 |
| 2 | 16/117 | 13.7 |
| 3 | 12/117 | 10.3 |
| 4 | 20/117 | 17.1 |
| 5 | 15/117 | 12.8 |
| 6 | 11/117 | 9.4 |
| ≥ 7 | 14/117 | 12.0 |
| Acquisition type and infection/colonization status* | ||
| Hospital acquisition | 95/116 | 81.9 |
| Community acquisition | 21/116 | 18.1 |
| Infection | 76/123 | 61.8 |
| Colonization | 47/123 | 38.2 |
| Deceased* | ||
| Death associated with P. aeruginosa | 9/112 | 8.0 |
| Antibiotic treatment with an antipseudomonal* | ||
| Treated before strain identification | 25/100 | 25.0 |
| Treated after strain identification | 62/102 | 60.8 |
*Not found cases were excluded from the total.